Biology and Evolution of Microorganisms

The Biology and Evolution of Microorganisms Group, whose head is Dr. Rafael Cantón and which is made up of nine other principal investigators as well as numerous pre- and post-doctoral researchers, technicians and other healthcare personnel, has participated in the last 5 years in 17 national and international research projects and in 15 contracts with pharmaceutical companies or companies dedicated to in vitro diagnostics. During this period of time this work has resulted in more than 190 publications in national and international journals with a high impact index and more than 11 doctoral theses. Likewise, more than 400 communications have been presented at numerous national and international congresses. And all this always seeking the highest excellence in the fields of population biology, antibiotic resistance, respiratory infection, microbiota, metagenomics and HIV.

Search for publications

Only original articles, editorials, guidelines.

  • Castillo E, Felber M, Paule L, Juanola O, Wyss L, Wolfisberg T, Christensen S, Muñoz L, Miranda A, Ponce-Alonso M, de Dios O, Campo RD, Pastor O, Ortega MA, Álvarez-Mon M, Rollenske T, Moghadamrad S, de Gottardi A, Ganal-Vonarburg S, Yilmaz B, Lanza VF, Felli E, Kellmann P, Francés R, Albillos A, Wiest R.

    Non-selective ß-blockers reduce bacterial translocation by restoring gut barrier function during experimental cirrhosis.

    JOURNAL OF HEPATOLOGY . : .

    [doi:10.1016/j.jhep.2026.07.019]

  • Rubio-Martín E, Escudero-Sánchez R, López-Contreras J, Gutiérrez Liarte Á, Díaz Pollán B, De La Villa S, Llenas-García J, Marcelo Calvo C, Pérez Caballero G, Rodríguez Benavente AM, Ruiz-Mesa JD, Calabuig E, López Zúñiga MÁ, Rodríguez-Pardo D, Maestro De La Calle G, Merino Amador P, Salinas Botrán A, Mateo Flores J, Martínez Álvarez RM, Martínez García F, Ramos Merino L, Montero MM, Pinto Plá C, Pineda Í, Ibáñez Zurriaga A, Halperin AV, Muriel García A, Rodríguez-Baño J, Moreno Guillén S, Cobo J.

    Extended-pulsed fidaxomicin versus conventional dosing in patients at high risk of recurrence of Clostridioides difficile infection: a multicentre cohort study.

    CLINICAL MICROBIOLOGY AND INFECTION . : .

    [doi:10.1016/j.cmi.2026.07.005]

  • Pérez-Viso B, Hernández-García M, Martínez-Alonso E, Bengoechea JA, del Campo R, Cantón R, Avendaño-Ortiz J.

    Lipid A modification is associated with colistin susceptibility in Serratia nevei clinical isolates.

    Scientific Reports . : .

    [doi:10.1038/s41598-026-60418-9]

  • Pérez-Viso B, Hernández-García M, Fernández-de-Bobadilla MD, Baquero F, Aracil-Gisbert S, Coque TM, Del Campo R, Cantón R.

    The current discordance on Serratia spp. taxonomical diagnosis using proteomics or genomic tools.

    BMC MICROBIOLOGY . : .

    [doi:10.1186/s12866-026-05406-9]

  • Illescas-López M, Muñoz P, de Salazar A, Delgado R, Iborra A, Galán JC, Carracedo R, Sigcha M, López-Causape C, Fuentes A, Aguilera A, Marco-Sánchez C, García F.

    HIV-1 APOBEC-context mutations detected by next-generation sequencing in plasma: implications for drug resistance interpretation.

    JOURNAL OF INFECTIOUS DISEASES . : .

    [doi:10.1093/infdis/jiag277]